tiprankstipranks
Invesque Inc (TSE:IVQ)
TSX:IVQ
Want to see TSE:IVQ full AI Analyst Report?

Invesque (IVQ) AI Stock Analysis

10 Followers

Top Page

TSE:IVQ

Invesque

(TSX:IVQ)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
C$0.13
▼(-3.08% Downside)
Action:Reiterated
Date:05/15/26
The score is primarily held back by weak financial performance—steep revenue contraction, persistent losses, and recent cash burn—despite improved leverage. Technical signals are largely neutral with slightly negative momentum, and valuation is difficult to support because losses drive a negative P/E and there is no dividend yield data.
Positive Factors
Healthcare real estate focus
A concentrated business model in senior housing and long-term care aligns the company with durable demographic tailwinds (aging populations). Rental and JV-based cash flows are structurally recurring, supporting long-term revenue resilience if occupancy and operator health stabilize.
Negative Factors
Sharp revenue contraction and losses
A ~45% TTM revenue drop and steep net losses materially weaken core cash generation and operating scale. Persistent top-line deterioration impairs tenant/operator credit, reduces fixed-cost absorption, and makes sustained profitability unlikely without structural improvements or asset disposals.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthcare real estate focus
A concentrated business model in senior housing and long-term care aligns the company with durable demographic tailwinds (aging populations). Rental and JV-based cash flows are structurally recurring, supporting long-term revenue resilience if occupancy and operator health stabilize.
Read all positive factors

Invesque (IVQ) vs. iShares MSCI Canada ETF (EWC)

Invesque Business Overview & Revenue Model

Company Description
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022...
How the Company Makes Money
Invesque primarily makes money from real estate-related cash flows generated by its healthcare property portfolio. Key revenue and earnings sources typically include (1) rental income and lease payments from tenants/operators under lease structure...

Invesque Financial Statement Overview

Summary
Financials are pressured: Income Statement and Cash Flow scores are very weak (22 and 18) due to sharp TTM revenue decline (~45%), deep losses (net margin ~-41%), and meaningfully negative operating/free cash flow. The main offset is improved balance-sheet leverage (Balance Sheet score 48; debt-to-equity down to ~0.36x from ~3–4x historically), but ongoing losses and cash burn dominate.
Income Statement
22
Negative
Balance Sheet
48
Neutral
Cash Flow
18
Very Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue41.59M79.44M162.67M188.75M198.03M210.45M
Gross Profit16.62M29.39M59.00M72.41M95.59M90.97M
EBITDA-9.36M-9.72M24.27M-18.83M10.38M49.13M
Net Income-22.33M-32.04M-36.14M-99.24M-42.01M-28.54M
Balance Sheet
Total Assets102.85M130.80M637.22M828.28M1.10B1.30B
Cash, Cash Equivalents and Short-Term Investments10.50M39.26M18.16M10.74M27.58M19.37M
Total Debt6.13M33.52M394.84M588.25M765.46M893.75M
Total Liabilities8.20M36.69M518.05M681.18M865.69M1.01B
Stockholders Equity94.65M94.11M119.17M146.59M231.65M286.26M
Cash Flow
Free Cash Flow-14.99M-14.26M4.40M217.00K5.40M11.11M
Operating Cash Flow-13.64M-11.66M9.27M6.03M11.91M18.68M
Investing Cash Flow389.37M397.12M152.21M132.05M137.49M119.19M
Financing Cash Flow-378.21M-363.91M-154.07M-154.92M-141.19M-152.63M

Invesque Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.13
Price Trends
50DMA
0.13
Negative
100DMA
0.13
Negative
200DMA
0.13
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
45.39
Neutral
STOCH
41.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IVQ, the sentiment is Negative. The current price of 0.13 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.13, and above the 200-day MA of 0.13, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.39 is Neutral, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:IVQ.

Invesque Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
C$34.50M-223.314.41%2.31%0.99%57.64%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
62
Neutral
C$1.54B3,070.9210.42%0.09%6.33%-23.45%
61
Neutral
C$127.70M-23.029.18%-4.57%
50
Neutral
C$1.56B-29.67-14.88%0.25%11.12%55.62%
50
Neutral
C$125.85M-10.18-8.54%10.31%-4.10%48.99%
44
Neutral
C$104.04M72.09-28.36%-73.49%95.20%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:IVQ
Invesque
0.14
-0.01
-10.00%
TSE:IEI
Imperial Equities
3.65
0.13
3.69%
TSE:MEQ
Mainstreet Equity
165.60
-24.90
-13.07%
TSE:SVI
Storagevault Canada
4.29
0.51
13.52%
TSE:PKT
Parkit Enterprise
0.60
0.18
42.86%
TSE:BRE
Bridgemarq Real Estate Services
13.43
0.29
2.18%

Invesque Corporate Events

Business Operations and StrategyFinancial DisclosuresM&A Transactions
Invesque Accelerates Asset Sales and Cuts Debt as Revenue Declines
Negative
Mar 19, 2026
Invesque reported a sharp reduction in its portfolio to seven owned assets at year-end 2025 after a series of asset disposals across the U.S. and Canada, including seniors housing properties and a medical office building. The company also fully re...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 15, 2026